Johnson & Johnson; Janssen Pharmaceuticals, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc.; and Janssen Pharmaceutica, Inc. n/k/a Janssen Pharmaceuticals, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Johnson & Johnson; Janssen Pharmaceuticals, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc.; and Janssen Pharmaceutica, Inc. n/k/a Janssen Pharmaceuticals, Inc.

Sort by

Viewing results 1‒25 of 27

Johnson & Johnson Co Inc
Talcum powder cancer claims target J&J’s new consumer carve-out
...Janssen is the pharmaceutical division of J&J....
April 27, 2023
Covid-19 vaccines
J&J says Covid booster shot produced strong antibody response
...A booster shot of Johnson & Johnson’s Covid-19 vaccine produced a strong and rapid antibody response against the virus, the pharmaceutical company said on Wednesday....
August 25, 2021
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Covid-19 vaccines
UK approves use of Johnson & Johnson vaccine
...The UK government on Friday authorised use of the Johnson & Johnson single-shot coronavirus vaccine, making it the fourth such jab to receive British approval to prevent Covid-19.The Department of Health...
May 28, 2021
Covid-19 vaccines
Johnson & Johnson seeks US authorisation for Covid-19 vaccine
...Johnson & Johnson has filed an application seeking emergency use authorisation for its Covid-19 vaccine with the Food and Drug Administration, bringing the company one step closer to getting the first single-shot...
February 4, 2021
Covid-19 vaccines
FDA moves to authorise Johnson & Johnson’s Covid-19 vaccine
...multiple clinical trials.Johan Van Hoof, global therapeutic area head at Janssen, J&J’s pharmaceutical division, told the panel on Friday: “Janssen’s vaccine candidate would play a critical role in the...
February 27, 2021
Covid-19 vaccines
Johnson & Johnson delays vaccine rollout in Europe after US health agencies call for pause
...Johnson & Johnson said it would delay the planned rollout of its Covid-19 vaccine in Europe after US health agencies called for a pause of the jab’s use on Americans while they investigate several incidents...
April 13, 2021
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Covid-19 vaccines
Johnson & Johnson vaccine shows 66% efficacy for moderate and severe Covid
...J&J is preparing to test a new formulation that could be targeted at the 501.v2 variant, but Mathai Mammen, global head of research and development for Janssen, J&J’s pharmaceuticals division, said he was...
January 29, 2021
Johnson & Johnson Co Inc
Johnson & Johnson to buy biotech Momenta in $6.5bn deal
...The deal will give J&J’s drugmaking division Janssen Pharmaceutica access to Momenta’s pipeline of products, including nipocalimab, a promising treatment for the rare muscular disease myasthenia gravis that...
August 19, 2020
Coronavirus treatment
J&J to launch UK trial of its Covid-19 vaccine
...US pharmaceutical group Johnson & Johnson is launching a UK trial of its experimental Covid-19 vaccine, after analysis of a rival jab last week sparked optimism that scientists are making progress in efforts...
November 16, 2020
News in-depthPharmaceuticals sector
Johnson & Johnson chief looks to the greater good
...The vaccine, Johnson & Johnson said, would be available on a not-for-profit basis....
April 3, 2020
Johnson & Johnson Co Inc
Johnson & Johnson faces court judgment over opioids crisis
...J&J — best known for consumer products such as “no more tears” baby shampoo — owns the Janssen pharmaceuticals business that sold two prescription opioids....
August 25, 2019
Pharmaceuticals sector
US approves first depression drug in decades
...Mathai Mammen, global head of Janssen Research and Development, a subsidiary of Johnson & Johnson, said Spravato was a “unique and innovative medicine” that had the potential to offer “new hope” to the third...
March 6, 2019
The Big ReadSarah Neville
Big pharma takes a gamble on NHS experiment
...Richard Mason, until recently European head of innovation at Johnson & Johnson, says 40 years ago the pharmaceutical industry “was based around little white pills for the masses....
August 28, 2018
US & Canadian companies
Johnson & Johnson unit speaks out at planned death row drug use
...It added: “Janssen discovers and develops medical innovations to save and enhance lives....
August 21, 2017
US & Canadian companies
Pfizer takes on J&J with antitrust lawsuit
...In a statement on Wednesday, Scott White, president at Janssen Biotech, a pharmaceuticals unit of J&J, said: “We are effectively competing on value and price and to date, Pfizer has failed to demonstrate...
September 20, 2017
FT Live
Infrastructure Investment in Latin America and the Caribbean
Identifying opportunities for investors and asset managers
Wednesday, 12 June237 Park Avenue, New York, NY, USA
Pharmaceuticals sector
Global health scares spur scientific innovation
...Johan Van Hoof, head of infectious diseases and vaccines at Janssen, part of the Johnson & Johnson pharmaceuticals group, says he also has cause for optimism....
April 24, 2016
Pharmaceuticals sector
Scientists make breakthrough in search for universal flu vaccine
...One team is a collaboration between the Scripps Research Institute in California and the Janssen Prevention Centre in the Netherlands, part of the Johnson and Johnson pharmaceutical group; the other is at...
August 24, 2015
Oil
Caterpillar falls on downgrade due to oil and gas exposure
...Shares of Isis Pharmaceuticals gained nearly 11 per cent to $69.19, after the company announced a collaboration with Janssen Biotech, a subsidiary of Johnson & Johnson, to develop drugs to treat autoimmune...
January 5, 2015
US & Canadian companies
Sweeteners, incentives – and abundant water supplies – help draw multinationals to Wallonia
...A European distribution centre opened in 2012 by Janssen Pharmaceutica (part of the multinational Johnson & Johnson) met all of the criteria set by the regional government and received €11m out of a total...
November 5, 2014
Pharmaceuticals sector
Signs of a revival in drug development
...Average R&D intensity — the percentage of revenue invested in R&D — among drugmakers is almost 15 per cent, according to research by Deloitte, commissioned by Janssen, the pharmaceuticals arm of Johnson...
December 10, 2014
Pharmaceuticals sector
Digital future signals more active role for the patient
...Bill Hait, global head of research and development for Janssen, the pharmaceuticals arm of Johnson & Johnson, says the combination of big data and advances in genomic science is greatly increasing the potential...
December 10, 2014
Sustainability
Green chemistry: Pharmaceutical companies try to clean up their act
...Addressing that issue is at the heart of Phil Dahlin’s role as director of sustainability for Janssen, the pharmaceuticals arm of Johnson & Johnson, the US consumer goods group....
June 29, 2014
EU economy
Tax deals raise questions over Ireland’s growth spurt
...According to the Irish Exporters Association, five pharma companies are among the top 20 Irish exporters — Johnson & Johnson (through its Janssen division), Pfizer, Boston Scientific, Gilead Sciences, and...
December 9, 2014
Pharmaceuticals sector
Drug development: Big pharma back in the game it made
...Peter Lebowitz, head of cancer research at Janssen, the pharmaceutical arm of Johnson & Johnson, says there is no guarantee the initial leaders will be the long-term winners....
September 25, 2014
Disease control and prevention
Hepatitis C researchers battle to ‘nuke’ the competition
...A step forward came from 2011 with the new so-called protease inhibitors from Merck, Vertex Pharmaceuticals and, more recently, Janssen, part of Johnson & Johnson....
July 27, 2014

Previous pagePage 1 of 2Next page